Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/114083
DC FieldValueLanguage
dc.contributor.authorFilgueira, Tayrine Ordonio-
dc.contributor.authorCarvalho, Paulo Roberto Cavalcanti-
dc.contributor.authorde Sousa Fernandes, Matheus Santos-
dc.contributor.authorCastoldi, Angela-
dc.contributor.authorTeixeira, Ana-
dc.contributor.authorde Albuquerque, Renata Bezerra-
dc.contributor.authorde Lima-Filho, José Luiz-
dc.contributor.authorSouto, Fabrício Oliveira-
dc.date.accessioned2024-03-19T10:21:46Z-
dc.date.available2024-03-19T10:21:46Z-
dc.date.issued2022-
dc.identifier.issn1664-3224pt
dc.identifier.urihttps://hdl.handle.net/10316/114083-
dc.description.abstractCOVID-19 is an infectious disease caused by the SARS-CoV-2 virus, which induces a high release of pro-inflammatory chemokines and cytokines, leading to severe systemic disorders. Further, evidence has shown that recovered COVID-19 patients still have some symptoms and disorders from COVID-19. Physical exercise can have many health benefits. It is known to be a potent regulator of the immune system, which includes frequency, intensity, duration, and supervised by a professional. Given the confinement and social isolation or hospitalization of COVID-19 patients, the population became sedentary or opted for physical exercise at home, assuming the guarantee of the beneficial effects of physical exercise and reducing exposure to SARS-CoV-2. This study aimed to investigate the effects of a supervised exercise protocol and a home-based unsupervised exercise protocol on chemokine and cytokine serum levels in recovered COVID-19 patients. This study was a prospective, parallel, two-arm clinical trial. Twenty-four patients who had moderate to severe COVID-19 concluded the intervention protocols of this study. Participants were submitted to either supervised exercise protocol at the Clinical Hospital of the Federal University of Pernambuco or home-based unsupervised exercise for 12 weeks. We analyzed serum levels of chemokines (CXCL8/IL-8, CCL5/RANTES, CXCL9/MIG, CCL2/MCP-1, and CXCL10/IP-10) and cytokines (IL-2, IL-4, IL-6, IL-10, IL-17A, TNF-α, and IFN-γ). Before the interventions, no significant differences were observed in the serum levels of chemokines and cytokines between the supervised and home-based unsupervised exercise groups. The CXCL8/IL-8 (p = 0.04), CCL2/MCP-1 (p = 0.03), and IFN-γ (p = 0.004) levels decreased after 12 weeks of supervised exercise. In parallel, an increase in IL-2 (p = 0.02), IL-6 (p = 0.03), IL-4 (p = 0.006), and IL-10 (p = 0.04) was observed after the supervised protocol compared to pre-intervention levels. No significant differences in all the chemokines and cytokines were found after 12 weeks of the home-based unsupervised exercise protocol. Given the results, the present study observed that supervised exercise was able to modulate the immune response in individuals with post-COVID-19, suggesting that supervised exercise can mitigate the inflammatory process associated with COVID-19 and its disorders.pt
dc.language.isoengpt
dc.publisherFrontiers Media S.A.pt
dc.relationCoordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brazil (CAPES)pt
dc.relationCAPES (88887.470105/ 2019-00)pt
dc.relationFACEPE (BFP-0102-1.11/19)pt
dc.relationCNPq (159958/2019-9)pt
dc.rightsopenAccesspt
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt
dc.subjectsupervised exercise protocolpt
dc.subjecthome-based exercisept
dc.subjectimmune biomarkerspt
dc.subjectchemokinespt
dc.subjectcytokinespt
dc.subjectCOVID-19pt
dc.subject.meshHumanspt
dc.subject.meshInterleukin-10pt
dc.subject.meshInterleukin-8pt
dc.subject.meshInterleukin-6pt
dc.subject.meshInterleukin-4pt
dc.subject.meshInterleukin-2pt
dc.subject.meshProspective Studiespt
dc.subject.meshSARS-CoV-2pt
dc.subject.meshChemokinespt
dc.subject.meshCytokinespt
dc.subject.meshCOVID-19pt
dc.titleThe impact of supervised physical exercise on chemokines and cytokines in recovered COVID-19 patientspt
dc.typearticle-
degois.publication.firstPage1051059pt
degois.publication.titleFrontiers in Immunologypt
dc.peerreviewedyespt
dc.identifier.doi10.3389/fimmu.2022.1051059pt
degois.publication.volume13pt
dc.date.embargo2022-01-01*
uc.date.periodoEmbargo0pt
item.grantfulltextopen-
item.cerifentitytypePublications-
item.languageiso639-1en-
item.openairetypearticle-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextCom Texto completo-
crisitem.author.researchunitCIDAF - Research Unit for Sport and Physical Activity-
crisitem.author.orcid0000-0003-1498-949X-
Appears in Collections:FCDEF - Artigos em Revistas Internacionais
Show simple item record

Page view(s)

17
checked on May 8, 2024

Download(s)

3
checked on May 8, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons